Multaq (dronedarone) - Important Safety Information from Sanofi-aventis as approved by the Irish Medicines Board
02 August 2011
Important Safety Information communication from Sanofi-aventis on Multaq (dronedarone) following preliminary study results showing increased cardiovascular risk.
Important Safety Information - Multaq